findmyKOL

James Kerner, MD, PhD

Basic profile

Dermatology

ORCIDNone on fileNPI
RegionLas Cruces, NM · WestSpecialtyDermatologyFocusDermatology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

James Kerner is a Dermatology physician. OpenAlex indexes 7 publications with 1,006 citations (h-index 5).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
7publications

Distinct works indexed by OpenAlex.

1,006citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
26companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

141 N Roadrunner Pkwy Ste 228
Las Cruces, NM 880112001

Telephone

575-521-1177

Provider last certified this registry record 16 Feb 2023.

View the NPPES registry record

Industry payments

26 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Dermatology

    27.1%
    Antivirals13.3%
    Imiquimod100%
    Part D853 patients
    Corticosteroid6.4%
    Triamcinolone Acetonide84%Fluocinolone Acetonide16%
    Part D285 patients

    + 8 more classes in this area

  • Anti-infectives

    18.8%
    Azole Antifungal7.3%
    Ketoconazole97%Fluconazole3%
    Part D291 patients
    Tetracycline-class Drug5.3%
    Doxycycline Hyclate72%Minocycline Hcl17%Doxycycline Monohydrate10%
    Part D98 patients

    + 6 more classes in this area

  • Respiratory

    12.9%
    RNA Synthetase Inhibitor Antibacterial9.4%
    Mupirocin100%
    Part D634 patients
    Corticosteroid3.2%
    Mometasone Furoate100%
    Part D190 patients

    + 2 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”